New spray aims to speed healing of stubborn diabetic foot sores

NCT ID NCT07396376

Recruiting now Symptom relief Sponsor: Eluciderm Inc Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests a topical spray called ELU42 on 15 adults with diabetic foot ulcers (Wagner grade 1-2) that have lasted 4 to 52 weeks. The spray is applied three times a week for six weeks. The main goals are to check safety and measure how much the wound shrinks. This is not a cure, but aims to ease symptoms and help the wound close.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC WOUND are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic ulcer of skin Diabetic Foot injury Wagner disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC WOUND DIABETIC FOOT ULCER OPEN WOUND WAGNER GRADE 1 - 2

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Curalta Clinical Trials
RECRUITING

Oradell, New Jersey, 07649, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Futuro Clinical Trials
RECRUITING

McAllen, Texas, 78501, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Gateway Clinical Trials
RECRUITING

O'Fallon, Illinois, 62269, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••
Independent Clincal Research LLC
RECRUITING

Springfield, Illinois, 62704, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.